Drugs / OTS167IV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02768519 | Jan → Feb 2016 | — | OncoTherapy Science, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OTS167IV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02768519 ↗ |
| Route | Oral | “when administered by the oral route” NCT02768519 ↗ |